119 related articles for article (PubMed ID: 35400081)
1. Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study.
Williams P; Burke T; Norquist JM; Daskalopoulou C; Speck RM; Samkari A; Eremenco S; Coons SJ
JTO Clin Res Rep; 2022 Apr; 3(4):100298. PubMed ID: 35400081
[TBL] [Abstract][Full Text] [Related]
2. Non-Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure.
Bushnell DM; Atkinson TM; McCarrier KP; Liepa AM; DeBusk KP; Coons SJ;
Curr Ther Res Clin Exp; 2021; 95():100642. PubMed ID: 34567289
[TBL] [Abstract][Full Text] [Related]
3. GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS
Gounder MM; Atkinson TM; Bell T; Daskalopoulou C; Griffiths P; Martindale M; Smith LM; Lim A
Qual Life Res; 2023 Oct; 32(10):2861-2873. PubMed ID: 37347393
[TBL] [Abstract][Full Text] [Related]
4. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
[TBL] [Abstract][Full Text] [Related]
5. Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.
Speck RM; Yu R; Ford JH; Ayer DW; Bhandari R; Wyrwich KW
Headache; 2021 Mar; 61(3):511-526. PubMed ID: 33481276
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
7. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough.
Martin Nguyen A; Bacci E; Dicpinigaitis P; Vernon M
Ther Adv Respir Dis; 2020; 14():1753466620915155. PubMed ID: 32345170
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
9. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
Wright DD; Paty J; Turner-Bowker DM; Bradbury A
Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
[TBL] [Abstract][Full Text] [Related]
10. Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC.
Barlesi F; Garon EB; Kim DW; Felip E; Han JY; Kim JH; Ahn MJ; Fidler MJ; Gubens MA; de Castro G; Surmont V; Li Q; Deitz AC; Lubiniecki GM; Herbst RS
J Thorac Oncol; 2019 May; 14(5):793-801. PubMed ID: 30711649
[TBL] [Abstract][Full Text] [Related]
11. Symptom assessment in relapsed small cell lung cancer: cross-validation of the patient symptom assessment in lung cancer instrument.
Chen L; Antras L; Duh MS; Neary M; O'Brien ME
J Thorac Oncol; 2008 Oct; 3(10):1137-45. PubMed ID: 18827610
[TBL] [Abstract][Full Text] [Related]
12. Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
Shih VH; Slagle AF; Ivanescu C; Flore G; Meyers O; Kreindler J; Martin UJ; Werkström V
Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1638-1648. PubMed ID: 37271980
[TBL] [Abstract][Full Text] [Related]
13. Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.
Coon CD; Hanlon J; Abel JL; Lundy JJ; Carson RT; Reasner DS
Value Health; 2020 Mar; 23(3):362-369. PubMed ID: 32197732
[TBL] [Abstract][Full Text] [Related]
14. Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study.
Cardellino A; Shah M; Hanlon J; Kelly K; Martin A; de Climens AR; Taiyari S; Stojadinovic A
Front Psychol; 2023; 14():1217793. PubMed ID: 37744571
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of self-report concussion scales and checklists.
McLeod TC; Leach C
J Athl Train; 2012; 47(2):221-3. PubMed ID: 22488289
[TBL] [Abstract][Full Text] [Related]
16. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).
Hudgens S; Phillips-Beyer A; Newton L; Seboek Kinter D; Benes H
Patient; 2021 Mar; 14(2):249-268. PubMed ID: 33131027
[TBL] [Abstract][Full Text] [Related]
18. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the Sexual Adjustment Questionnaire (SAQ) in the Iranian population with spinal cord injury.
Merghati-Khoei E; Maasoumi R; Rahdari F; Bayat A; Hajmirzaei S; Lotfi S; Hajiaghababaei M; Emami-Razavi SH; Korte JE; Atoof F
Spinal Cord; 2015 Nov; 53(11):807-10. PubMed ID: 25917953
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.
Gelhorn HL; Dashiell-Aje E; Miller MG; DeRogatis LR; Dobs A; Seftel AD; Althof SE; Brod M; Revicki DA
J Sex Med; 2016 Nov; 13(11):1737-1749. PubMed ID: 27692845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
